Clinical Trials Browser

Doxorubicin × Tumor-Agnostic × 90 days × Clear all

NCT03907475 2026-05-13

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Phase 2 Recruiting

Neoplasm Metastasis